{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1219.82","meta":{"versionId":"9","lastUpdated":"2022-03-15T01:04:14.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CMS DRLS Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-03-15"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1219.82"}],"version":"20220315","name":"ImmunosuppressiveMedicationHCPCS","title":"Immunosuppressive Medication HCPCS","status":"active","experimental":false,"date":"2022-03-15T01:04:14-04:00","publisher":"CMS DRLS Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Immunosuppressive medications including dose and route of administration.),(Data Element Scope: Immunosuppressive medications, dose and route of administration that are reported to the US Centers for Medicare and Medicaid using J codes from the Healthcare Common Procedure Coding System (HCPCS) code system.),(Inclusion Criteria: Immunosuppressive medications, route of administration and dose that are reported to the US Centers for Medicare and Medicaid.),(Exclusion Criteria: Immunosuppressive medications, route of administration and dose that are not reported to the US Centers for Medicare and Medicaid.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"J0485","display":"Injection, belatacept, 1 mg"},{"code":"J7500","display":"Azathioprine, oral, 50 mg"},{"code":"J7501","display":"Azathioprine, parenteral, 100 mg"},{"code":"J7503","display":"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg"},{"code":"J7504","display":"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg"},{"code":"J7505","display":"Muromonab-cd3, parenteral, 5 mg"},{"code":"J7507","display":"Tacrolimus, immediate release, oral, 1 mg"},{"code":"J7508","display":"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg"},{"code":"J7511","display":"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg"},{"code":"J7513","display":"Daclizumab, parenteral, 25 mg"},{"code":"J7517","display":"Mycophenolate mofetil, oral, 250 mg"},{"code":"J7518","display":"Mycophenolic acid, oral, 180 mg"},{"code":"J7520","display":"Sirolimus, oral, 1 mg"},{"code":"J7525","display":"Tacrolimus, parenteral, 5 mg"},{"code":"J7527","display":"Everolimus, oral, 0.25 mg"},{"code":"J7599","display":"Immunosuppressive drug, not otherwise classified"},{"code":"J8610","display":"Methotrexate; oral, 2.5 mg"}]}]},"expansion":{"identifier":"urn:uuid:ca7101f8-b28c-418e-9c2b-7bbc8024f84b","timestamp":"2023-12-10T23:48:31-05:00","total":17,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J0485","display":"Injection, belatacept, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7500","display":"Azathioprine, oral, 50 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7501","display":"Azathioprine, parenteral, 100 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7503","display":"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7504","display":"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7505","display":"Muromonab-cd3, parenteral, 5 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7507","display":"Tacrolimus, immediate release, oral, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7508","display":"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7511","display":"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7513","display":"Daclizumab, parenteral, 25 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7517","display":"Mycophenolate mofetil, oral, 250 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7518","display":"Mycophenolic acid, oral, 180 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7520","display":"Sirolimus, oral, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7525","display":"Tacrolimus, parenteral, 5 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7527","display":"Everolimus, oral, 0.25 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7599","display":"Immunosuppressive drug, not otherwise classified"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J8610","display":"Methotrexate; oral, 2.5 mg"}]}}